Corvus Pharmaceuticals Inc (NASDAQ:CRVS)
| 1.74 Delayed Data As of 3:54pm ET |  -0.06 / -3.33%Today’s Change | 1.60 Today|||52-Week Range 9.54 | -27.80% Year-to-Date |
Latest CRVS News | Press Releases
No recent news for Corvus Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.80 |
| Today’s open | 1.76 |
| Day’s range | 1.75 - 1.86 |
| Volume | 4,088 |
| Average volume (3 months) | 6,121,939 |
| Market cap | $82.4M |
Data as of 3:54pm ET, 01/26/2022
Growth & Valuation
| Earnings growth (last year) | +87.21% |
| Earnings growth (this year) | -381.25% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | 19.3 |
| Price/Sales | -- |
| Price/Book | 0.70 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| ASMBAssembly Biosciences... | -0.03 | -2.00% |
| CAPRCapricor Therapeutic... | -0.27 | -7.85% |
| LPCNLipocine Inc | -0.03 | -3.02% |
| SIOXSio Gene Therapies I... | 0.00 | 0.00% |
Data as of 4:00pm ET, 01/26/2022
Financials
| Next reporting date | March 10, 2022 |
| EPS forecast (this quarter) | -$0.19 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$6.0M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burlingame, California |
Forecasts
